The Bioactive Ingredient Quercetin in Guilu‐Erxian‐Glue Ameliorates Oligoasthenospermia in Mice via PKA/CREB Pathway‐Dependent Sirt1 Activation and p53 Deacetylation
Molecular Reproduction and Development · 2025
DOI: 10.1002/mrd.70036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Reproduction and Development, 2025. Verfasst von Yingqiu Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, Hunan University of Chinese Medicine, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Sirtuin 1, Quercetin, Tumor Suppressor Protein p53, Cyclic AMP Response Element-Binding Protein. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: This study was supported by National Innovation and Entrepreneurship Training Program for college students and Research Innovation Foundation of Hunan Universi….
Abstract (Originalsprache)
Oligoasthenospermia (OAS), a major cause of male infertility, was alleviated by Guilu‐Erxian‐Glue (GLEXG) in Tripterygium wilfordii polyglycoside (TWG)‐induced rat models. This study identified GLEXG's bioactive ingredients and explored its therapeutic mechanism. Using network pharmacology and liquid chromatography‐mass spectrometry, quercetin was predicted and validated as a key component of GLEXG. In vivo and in vitro, OAS models were established using TWG in mice and H 2 O 2 in spermatocytes. TWG administration reduced testicle and epididymis indices, sperm concentration, vitality, and serum testosterone, luteinizing hormone, and follicle‐stimulating hormone. It also increased germ cell apoptosis, upregulated Bax, cleaved caspase‐3, and cleaved caspase‐9, downregualted Bcl‐2, PHB1, VDHC, SDHA, and CoxIV, and impaired mitochondrial function (reduced mitochondrial DNA copy number and membrane potential). Quercetin counteracted these effects in vivo and in vitro. Mechanistically, quercetin increased p‐PKA/PKA and p‐CREB/CREB ratios, upregulated Sirt1, and decreased Ac‐p53/p53 ratio. These beneficial effects were abolished upon Sirt1 inhibition. Thus, quercetin in GLEXG ameliorated OAS by attenuating apoptosis and mitochondrial dysfunction via PKA/CREB pathway‐dependent activation of Sirt1 and deacetylation of p53.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical School, Hunan University of Chinese Medicine, Changsha, Hunan, China.
- School of Acupuncture-Moxibustion, Tuina and Rehabilitation, Hunan University of Chinese Medicine, Changsha, Hunan, China.
- School of Traditional Chinese Medicine, Hunan University of Medicine, Huaihua, Hunan, China.
- Andrology Laboratory, Hunan University of Chinese Medicine, Changsha, Hunan, China.
ORCID-Profile: Wen Sheng
Förderung
- This study was supported by National Innovation and Entrepreneurship Training Program for college students and Research Innovation Foundation of Hunan Universi…
Zitieren
APA
Li, Y., Tian, X., Wang, M., Tang, C., Du, X., Dai, L., Ding, Z., Zhao, Q., He, Q., & Sheng, W. (2025). The Bioactive Ingredient Quercetin in Guilu‐Erxian‐Glue Ameliorates Oligoasthenospermia in Mice via PKA/CREB Pathway‐Dependent Sirt1 Activation and p53 Deacetylation. Molecular Reproduction and Development. https://doi.org/10.1002/mrd.70036
Vancouver
Li Y, Tian X, Wang M, Tang C, Du X, Dai L, et al. The Bioactive Ingredient Quercetin in Guilu‐Erxian‐Glue Ameliorates Oligoasthenospermia in Mice via PKA/CREB Pathway‐Dependent Sirt1 Activation and p53 Deacetylation. Molecular Reproduction and Development. 2025. doi:10.1002/mrd.70036
BibTeX
@article{Li2025,
author = {Li, Yingqiu and Tian, Xianyu and Wang, Minglian and Tang, Chenxi and Du, Xinyu and Dai, Ling and Ding, Zhanglei and Zhao, Qinkun and He, Qinghu and Sheng, Wen},
title = {The Bioactive Ingredient Quercetin in Guilu‐Erxian‐Glue Ameliorates Oligoasthenospermia in Mice via PKA/CREB Pathway‐Dependent Sirt1 Activation and p53 Deacetylation},
journal = {Molecular Reproduction and Development},
year = {2025},
doi = {10.1002/mrd.70036}
}
EUVIMED